US Patent 7253187 Heterocyclic inhibitors of ERK2 and uses thereof
Patent 7253187 was granted and assigned to Vertex Pharmaceuticals on August, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
Described herein are compounds that are useful as protein kinase inhibitors having the formula:
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07253187 Heterocyclic inhibitors of ERK2 and uses thereof US Patent 7253187 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Patent Number
0725318700
Patent Number
725318700
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072531870
Date of Patent
August 7, 2007
0Patent Application Number
107708140
Date Filed
February 3, 2004
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072531870
Date of Patent
August 7, 2007
0Patent Application Number
107708140
Date Filed
February 3, 2004
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07253187 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07253187
Date of patent
August 7, 2007
Patent application number
10770814
Date Filed
February 3, 2004
Patent primary examiner
Find more entities like US Patent 7253187 Heterocyclic inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
